Praxis Precision Medicines Stock Analysis

PRAX Stock  USD 71.14  3.99  5.31%   
Praxis Precision Medicines is overvalued with Real Value of 34.08 and Target Price of 7.08. The main objective of Praxis Precision stock analysis is to determine its intrinsic value, which is an estimate of what Praxis Precision Medicines is worth, separate from its market price. There are two main types of Praxis Precision's stock analysis: fundamental analysis and technical analysis.
The Praxis Precision stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Praxis Precision is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Praxis Stock trading window is adjusted to America/New York timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Praxis Precision Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Praxis Stock Analysis Notes

About 100.0% of the company shares are owned by institutional investors. The book value of Praxis Precision was at this time reported as 21.52. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Praxis Precision Med recorded a loss per share of 9.17. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 29th of November 2023. Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people. To find out more about Praxis Precision Medicines contact Marcio MBA at 617 300 8460 or learn more at https://praxismedicines.com.

Praxis Precision Med Investment Alerts

Praxis Precision Med had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (123.28 M) with profit before overhead, payroll, taxes, and interest of 0.
Praxis Precision Medicines currently holds about 165.4 M in cash with (111.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7.
Praxis Precision Med has a frail financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Praxis Precision Medicines, Inc. Shares Sold by Fmr LLC - MarketBeat

Praxis Precision Med Upcoming and Recent Events

Earnings reports are used by Praxis Precision to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
6th of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Praxis Largest EPS Surprises

Earnings surprises can significantly impact Praxis Precision's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-11
2023-03-31-0.79-0.710.0810 
2023-02-07
2022-12-31-0.78-0.87-0.0911 
2023-11-07
2023-09-30-0.35-0.180.1748 
View All Earnings Estimates

Praxis Precision Environmental, Social, and Governance (ESG) Scores

Praxis Precision's ESG score is a quantitative measure that evaluates Praxis Precision's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Praxis Precision's operations that may have significant financial implications and affect Praxis Precision's stock price as well as guide investors towards more socially responsible investments.

Praxis Stock Institutional Investors

Shares
Verition Fund Managegment, Llc2024-09-30
559.2 K
Hhg Plc2024-09-30
523.6 K
Franklin Resources Inc2024-09-30
445.2 K
Geode Capital Management, Llc2024-09-30
398.8 K
Kingdon Capital Management Llc2024-09-30
368 K
Velan Capital Investment Management Lp2024-09-30
350.7 K
5am Venture Management, Llc2024-09-30
340 K
Baker Bros Advisors Lp2024-09-30
323.1 K
Nuveen Asset Management, Llc2024-09-30
304.8 K
Blackrock Inc2024-06-30
1.3 M
Perceptive Advisors Llc2024-09-30
1.2 M
Note, although Praxis Precision's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Praxis Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.4 B.

Praxis Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.40)(1.47)
Return On Capital Employed(1.75)(1.84)
Return On Assets(1.40)(1.47)
Return On Equity(1.77)(1.86)

Management Efficiency

Praxis Precision Med has return on total asset (ROA) of (0.392) % which means that it has lost $0.392 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6434) %, meaning that it created substantial loss on money invested by shareholders. Praxis Precision's management efficiency ratios could be used to measure how well Praxis Precision manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.47 in 2024. Return On Capital Employed is likely to drop to -1.84 in 2024. At this time, Praxis Precision's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 108.3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 3 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 10.57  10.04 
Tangible Book Value Per Share 10.57  10.04 
Enterprise Value Over EBITDA(0.54)(0.57)
Price Book Value Ratio 2.11  1.62 
Enterprise Value Multiple(0.54)(0.57)
Price Fair Value 2.11  1.62 
Enterprise Value68.1 M116.3 M
Evaluating the management effectiveness of Praxis Precision allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Praxis Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(188.20)
Beta
2.687
Return On Assets
(0.39)
Return On Equity
(0.64)

Technical Drivers

As of the 12th of December 2024, Praxis Precision holds the Coefficient Of Variation of 889.36, risk adjusted performance of 0.0893, and Semi Deviation of 3.13. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Praxis Precision, as well as the relationship between them.

Praxis Precision Med Price Movement Analysis

Execute Study
The output start index for this execution was fourty-one with a total number of output elements of twenty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Praxis Precision middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Praxis Precision Med. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Praxis Precision Med Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Praxis Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Praxis Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Praxis Precision insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Praxis Precision Outstanding Bonds

Praxis Precision issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Praxis Precision Med uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Praxis bonds can be classified according to their maturity, which is the date when Praxis Precision Medicines has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Praxis Precision Predictive Daily Indicators

Praxis Precision intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Praxis Precision stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Praxis Precision Corporate Filings

F4
19th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
15th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
12th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
8th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
8K
6th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
4th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
22nd of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify

Praxis Precision Forecast Models

Praxis Precision's time-series forecasting models are one of many Praxis Precision's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Praxis Precision's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Praxis Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Praxis Precision prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Praxis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Praxis Precision. By using and applying Praxis Stock analysis, traders can create a robust methodology for identifying Praxis entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(45.34)(47.61)
Operating Profit Margin(46.48)(48.80)
Net Loss(45.34)(47.61)

Current Praxis Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Praxis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Praxis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.08Strong Buy10Odds
Praxis Precision Medicines current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Praxis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Praxis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Praxis Precision Med, talking to its executives and customers, or listening to Praxis conference calls.
Praxis Analyst Advice Details

Praxis Stock Analysis Indicators

Praxis Precision Medicines stock analysis indicators help investors evaluate how Praxis Precision stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Praxis Precision shares will generate the highest return on investment. By understating and applying Praxis Precision stock analysis, traders can identify Praxis Precision position entry and exit signals to maximize returns.
Begin Period Cash Flow62 M
Common Stock Shares Outstanding6.6 M
Total Stockholder Equity69.7 M
Property Plant And Equipment Net2.7 M
Cash And Short Term Investments81.3 M
Cash81.3 M
Accounts Payable5.8 M
Net Debt-78.8 M
50 Day M A71.728
Total Current Liabilities15.7 M
Other Operating Expenses128.8 M
Non Current Assets Total3.1 M
Non Currrent Assets Other416 K
Stock Based Compensation24.9 M

Additional Tools for Praxis Stock Analysis

When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.